About This Webinar
Atherosclerotic vascular disease is the leading cause of mortality in women. Although biology of the disease is the same, the risk factors may differ, and gender specific risk factors and conditions alter the course of the disease. With worsening epidemics of diabetes and obesity, women are getting the disease in younger ages especially in middle income countries. Dyslipidemia is prevalent among women who undergo a number of hormonal changes throughout their lives that have significant effects on lipoprotein metabolism. With menopause,women not only experience a worsening of their lipid profile, with transition to higher and more atherogenic dyslipidemia but also have an increased tendency to gain weight and blood pressure. Despite some improvement in recent years, underdiagnosis and undertreatment in women is still an issue. In addition to atherosclerotic vascular disease, MINOCA and INOCA are seen more frequently in women. Top experts in the field will be discussing the novel information we have on women, dyslipidaemia and atherosclerosis in this webinar and you will have the opportunity to interact with them.

AGENDA

Chair: Lale TOKGÖZOĞLU

Dyslipidaemia in women Jeanine ROETERS VAN LENNEP

Atherosclerotic vascular disease in women Erin MICHOS

Why are diabetic women not protected against ASVD Fabrice BONNET

Discussion Lale TOKGÖZOĞLU

Presenters
  • 1617702221-0a8265007e89fdf8
    Fabrice BONNET
    University of Rennes, France
    Professor Fabrice Bonnet, MD, PhD, was appointed to the Chair of Endocrinology at the University of Rennes (France) in 2007 and also has clinical activity in the Department of Diabetes at the University Hospital of Rennes.

    His medical degree and PhD were from the University of Lyon, France.
    He worked on experimental models of diabetic vascular complication, and studied the lonk between both insulin resistance and alterations in insulin secretion and vascular complications. He belongs to a scientific research team working on the epidemiology of diabetes and vascular complications.

    He has published over 200 publications in peer reviewed journals.
    He is editor-in-chief of Diabetes & Metabolism, the scientific journal of the French Society since 2013 (last impact factor of 4.74).
  • 1617702297-4fa71355ac512ce4
    Erin MICHOS
    Johns Hopkins School of Medicine, USA
    Dr. Erin Michos is an Associate Professor of Medicine in the Division of Cardiology at the Johns Hopkins University School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women’s Cardiovascular Heath and the Associate Director of Preventive Cardiology.

    Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health and has authored over 400 publications. Her research has focused on (1) cardiovascular disease prevention among women; (2) coronary artery calcium, inflammation and other novel biomarkers of cardiovascular risk prediction; (3) lipids and lipid treatment; (4) cardio-metabolic diseases and (5) vitamin D, calcium, and other supplements.

    She is the co-Editor in Chief for the American Journal of Preventive Cardiology and a past Associate Editor for Circulation. She is a member of the Board of Directors for the American Society of Preventive Cardiology (ASPC).

    Dr. Michos is a co-investigator in several National Institute of Health studies including the Multi-Ethnic Study of Atherosclerosis (MESA) and the Atherosclerosis Risk in Communities (ARIC) cohorts. Dr. Michos is the Training Director for three American Heart Association Strategic Focused Research Networks. She is the recipient of 2 mentoring award at the Johns Hopkins School of Medicine.

    Dr. Michos completed medical school at Northwestern University and then completed both Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital. She also completed a Masters of Health Science degree in Cardiovascular Epidemiology at the Johns Hopkins Bloomberg School of Public Health.
  • 1617702317-c23727bf260c279a
    Jeanine ROETERS VAN LENNEP
    Erasmus Medical Center, The Netherlands
    Jeanine Roeters van Lennep has been working as internist specialized in vascular medicine at the Erasmus Medical Center, Rotterdam, the Netherlands since 2010. She is head of the lipid clinic specialized in hereditary dyslipidemia treating adults and children. She combines this research interest with gender-specific medicine.
    As such, her scientific research is dedicated to cardiovascular prevention, specifically diagnosis and treatment of Familial Hypercholesterolemia and sex-specific cardiovascular risk factors such as pre-eclampsia for which she obtained grants of e.g. the Dutch Heart Foundation and the Dutch Research Council.

    She is very eager to share her enthusiasm on sex- and gender specific medicine by organizing educational activities such as the 3-day Gender and Health Course and mentoring junior doctors and researchers.
    She also organized the very successful Pediatric Familial Hypercholesterolemia Symposium as an official satellite symposium of the 87th EAS congress in 2019.

    Jeanine has broad leadership experience as board member of various scientific societies. Currently she is chair of the Dutch Society of Vascular Medicine, chair of the HORIZONSCAN cardiovascular drugs committee of the Dutch National Healthcare Institute and board member of the Dutch Society of Gender and Health. Moreover she has been chair of the first Dutch Guideline on Dyslipidemia.

    Since 2021 Jeanine is member of the executive board of the European Society.
  • 1617702785-1ed89432de55ff86
    Lale TOKGÖZOĞLU
    Hacettepe University Ankara, Turkey
    S. Lale Tokgözoğlu, MD, FACC, FESC is Professor of Cardiology at Hacettepe University, Ankara, Turkey. She is currently the President of the European Atherosclerosis Society and Deputy Editor of the European Heart Journal.

    Prof. Tokgözoğlu chaired the ‘Atherosclerosis and Vascular Biology Working Group of the European Society of Cardiology’ between 2008 and 2010. Prof. Tokgözoğlu has served on the Board of the Turkish Society of Cardiology and was elected to be the first female President of the Society in its history, between 2014-2016. During that time, she worked with the Ministry of Health to develop ‘Heart Health policies’ and strategies. She also chaired the Dyslipidaemia Working Group of the Turkish Society of Cardiology. She has contributed to several Guidelines and Consensus Papers on dyslipidaemia and Preventive Cardiology both in Europe and nationally. She was a member of the Steering Committee of the EUROASPIRE III-V studies which were the landmark studies defining preventive measures in Europe. She has also served on the Board of the Prevention Association as well as different committees of the European Society of Cardiology including the Fellowship and Training Committee, the Education Committee and currently the Research and Grants Committee. She is a member of the Science Academy and a founding member of the Atherosclerosis Research and Education Society in Turkey. She is founding member of the Department of Noncommunicable diseases in Hacettepe University. She serves on the Scientific and Research Council of Turkey Working Group on women researchers.

    Awards:
    Paul Dudley White Scence team award AHA 2017
    “Prof. Dr. Şeref Zileli “Resident of the Year” Award in 1987
    Sandoz Scientific Award in 1989
    “Young Investigator Award” of the Turkish Society of Cardiology in 1994
    Istanbul Medical Associaition Science Award in 2019